Newsbenzinga
Reported Earlier, Amylyx Pharmaceuticals Prices Upsized $500M Public Offering Of 14,090,000 Common Shares At $35.50 Per Share
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…